Idea Transcript
Search this site
Home (http://domain.com/)
About Us (http://domain.com/about-us/)
News and Press
Contact our team of experts to place an inquiry.
Dec 08, 2017 Dr. Michael Quirmbach comments on CordenPharma's recent acquisiton of CordenPharma Boulder in an interview with C&EN at CPhI 2017 entitled > Growth strategies for pharmaceutical chemical makers on display at CPhI. Leadership (http://domain.com/aboutus/leadership/)
Our History (http://domain.com/aboutus/our-history/)
Compliance (http://domain.com/aboutus/compliance/)
Nov 20, 2017 Article in Chemistry Today Sept / Oct 2017 > Oligonucleotides: Promising Therapeutics With Significant Challenges > by Dr. Matthieu Giraud & Christian Ahlmark
News and Press (http://domain.com/about-us/news-andpress/)
Events (http://domain.com/aboutus/events/)
ICIG (http://domain.com/about-us/icig/)
Nov 20, 2017 Pharma Horizon >> 5 Minutes at CPhI 2017 with Dr. Matthieu Giraud >> CordenPharma
Careers (http://domain.com/aboutus/careers/)
Browse brochures & presentations to learn more about CordenPharma.
Nov 20, 2017 Article >> Manufacturing Chemist, Nov 2017 >> Brian McCudden discusses new CordenPharma Boulder facility acquisition from Pfizer in Boulder, CO (US).
Nov 14, 2017 A recent article covering CordenPharma Plankstadt's new, fully-contained development lab for highly potent compounds utilizing Glatt's containment solutions.
Nov 03, 2017
by Christian Ahlmark (https://www.epmmagazine.com/topics/christian-ahlmark/) , Mario Scigliano (https://www.epmmagazine.com/topics/mario-scigliano/)
Packaging is integral to the fight against counterfeit medicines and serialisation of packaging is an essential tool with which companies and customers can use to verify drug products. Here, Mario Scigliano, serialisation & automation manager, and Christian Ahlmark, associate director, sales & key account management, CordenPharma, discuss how a CDMO can help give companies a fighting chance to be globally serialisation compliant.
Oct 16, 2017 CordenPharma announces a strategic investment of €3.7 million in the manufacturing site infrastructure of CordenPharma Switzerland (http://www.cordenpharma.com/facilities/switzerland/) , located in Liestal, Switzerland. The investment will include an expansion of the square footage dedicated to Small Molecule, Peptide and Carbohydrate development services.
Oct 10, 2017 CordenPharma announced it has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. The closing of the transaction is anticipated to occur in November 2017.
Oct 09, 2017
by Dr. Iris Ziegler, Director, Pharmaceutical Sciences & QbD, CordenPharma International Live Webinar Given Wednesday, October 4, 2017
Sep 13, 2017 CordenPharma is pleased to announce the completion of its newest early development suite for Highly Potent, oral solid dosage products in CordenPharma Plankstadt (DE). The new facility allows for the production of small batches, from 100g to approximately 1000g.
Aug 24, 2017 CordenPharma is pleased to announce that CordenPharma Latina, located near Sermoneta, Italy, has received news that the US-FDA warning letter previously received has been closed, with a closeout date of August 15, 2017. This success is the result of a holistic and systematic approach to remediate the observations throughout the facility.
Aug 02, 2017 CordenPharma Plankstadt is pleased to announce the design and installment of a new manufacturing line dedicated to producing Veterinary Drug Products for 500kg scale batch sizes to supply a complex innovative product for application in the veterinary health market. This new line is part of a production plant that is dedicated to Veterinary Drug Products.
Jun 28, 2017 Two leaders in research and biopharma manufacturing enter a strategic collaboration to meet customer need for a simplified, faster development proces. Chalfont St. Giles, UK and Plankstadt, Germany – June 28, 2017 – CordenPharma International and GE Healthcare’s Dharmacon business have entered a strategic collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.
Jun 01, 2017 Laval, Québec, CANADA – May 31, 2017 – Acasti Pharma Inc. (NASDAQ:ACST – TSX-V:ACST) today announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate, produced with a proprietary and innovative continuous manufacturing process developed in partnership with CordenPharma. CaPre is a potentially bestin-class omega-3 drug derived of krill oil and being developed for the treatment of patients with hypertriglyceridemia, a metabolic condition that contributes to the risk of cardiovascular disease and pancreatitis. The process was jointly designed and implemented by the Acasti and CordenPharma technical teams and engineers at the CordenPharma Chenôve facility in Dijon, France.
May 16, 2017 View the new Corden Pharma Colorado 2017 Video, featuring peptide, highly potent and oligonucleotide API development and manufacturing.
Apr 15, 2017 Drug Development & Delivery, April 2017 > Formulation Development & Manufacturing — CDMOs Offer Speed, Advanced Technologies, & the Ability to Handle More Potent APIs (http://www.drugdev.com/Main/Back-Issues/SPECIAL-FEATURE-Formulation-Development-Manufactur-1296.aspx) >
CordenPharma: Focusing on Small-Molecule Oncolytics (http://domain.com/assets/press-releases/ddd-april2017_cordenpharma-editorial-contribution.pdf/) >
by Jason Bertola, Director, Global Highly Potent & Oncology Platform
Mar 10, 2017 View the Recorded Webinar Archive >> From Market Compliance to Business Supply: The Necessity for Serialization (http://xtalks.com/TheNecessity-For-Serialization.ashx)
>> by Mario Scigliano >> Presented Live on March 8, 2017 >> To View the Webinar Archive >> Register Here (http://register.xtalks.com/surveys/Questions/SurveyMain.aspx? r=e42ba154-dabe-460b-a07b-425437087bfe&ma=1)
Mar 08, 2017 CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO), will be awarded 2017 CMO Leadership Awards (http://www.cmoleadershipawards.com/) presented by Life Science Leader (https://www.lifescienceleader.com/) magazine across all 6 Core Award Categories (including all 3 groups of Outsourcing Respondents) and all 8 Specialty Award Categories.
Feb 01, 2017 Webinar > From Market Compliance to Business Supply: The Necessity For Serialization > by Mario Sciglilano (http://xtalks.com/the-necessity-for-serialization.ashx) >> Wednesday, March 8, 2017 >> 16:00 EDT / 10:00 CET >> Register Here (https://attendee.gotowebinar.com/register/4516651209587219969)
Nov 03, 2016 C&EN White Paper >>
Brought to you by CordenPharma
Oct 17, 2016 As part of a long term growth strategy designed to meet increasing customer demands, CordenPharma has completed a recent key investment to strengthen development and manufacturing capabilities for API offerings across its Highly Potent & Oncology Platform (http://domain.com/highly-potent-oncology-platform/) .
Oct 16, 2016 View the Archive of a CordenPharma Webinar Organized by xTalks (http://www.xtalks.com/) >> Using Synthetic Carbohydrates as Biological Targeting & Delivery Agents (http://xtalks.com/UsingSynthetic-Carbohydrates-as-Delivery-Agents.ashx)
>> by Dr. Stewart Campbell, Head of Business Development & Product Management, Carbohydrates, CordenPharma Switzerland / Woburn >> Live Webinar Given Wednesday, November 2, 2016 >> Register for Archive Here (http://register.xtalks.com/surveys/Questions/SurveyMain.aspx?r=716ad7f2-ecaa4b68-ac72-c3bde1811b32&ma=0)
Oct 15, 2016 An article in the Boulder Daily Camera on October 4, 2016 > Highlights CordenPharma Colorado (http://domain.com/facilities/colorado/) as one of a dozen Boulder Valley companies to make the Colorado
Department of Public Health and Environment's list of super-clean companies (https://www.colorado.gov/pacific/cdphe/elp-company-profiles) . CordenPharma Colorado is named
Environmental Gold Leader. (https://www.colorado.gov/pacific/cdphe/elp/gold/corden-pharma)
Sep 29, 2016 Today Corden BioChem GmbH (http://domain.com/cordenbiochemwww.cordenbiochem.com/) announced that, starting October 1 st 2016 and going forward, the minimum pricing for any new order of 7-ACA will be $60 USD/kg. Corden BioChem will no longer accept any orders below this base pricing.
Aug 31, 2016 CordenPharma is pleased to announce that their CordenPharma Chenôve (http://domain.com/facilities/chenove/) (France) manufacturing facility recently completed an FDA Inspection
and received a successful response with no 483s reported. The last FDA Inspection took place in 2014.
Jul 25, 2016 Pharmaceutical Technology Interviews Dr. Michael Quirmbach, Vice President, Global Marketing & Sales, CordenPharma International > A Decade of CordenPharma > From Inception to FullService Provider
Jul 20, 2016 EuroPEPTIDES (https://lifesciences.knect365.com/europeptides/) , part of Tides Europe taking place November 14 - 17, 2016 in Berlin, Interviews Dr. Mimoun Ayoub, Director, Peptides, Lipids, Carbohydrates & Injectables Platforms on Peptide Vaccines.
Jul 01, 2016 CordenPharma is pleased to announce its expansion into the oligonucleotide Active Pharmaceutical Ingredient (API) development and manufacturing market in CordenPharma Colorado (http://domain.com/facilities/colorado/) (USA) to further strengthen its CDMO offering.
Jun 28, 2016 CordenPharma is pleased to announce the completion and approval of its aseptic filling line in CordenPharma Caponago (http://domain.com/facilities/caponago/) (IT) by the Italian AIFA for clinical and commercial supply.
Jun 24, 2016 The Colorado Department of Public Health and Environment (CDPHE) (https://www.colorado.gov/cdphe/ohe) Office of Health Equity (https://www.colorado.gov/cdphe/ohe) profiles the
environmental leadership and community outreach programs of CordenPharma Colorado (http://domain.com/facilities/colorado/) .
Jun 21, 2016 View an abstract of the poster to be given at the International Carbohydrate Symposium (http://www.ics2016.org/) , July 17-20, 2016 at the New Orleans Marriott, LA >> by Dr. Stewart Campbell, Head of
Business Development & Product Management, Carbohydrates >> Title: Protection against experimental melioidosis with a synthetic beta-manno-heptopyranose hexasaccharide glycoconjugate
Jun 15, 2016 CordenPharma & Weylchem (http://www.weylchem.com/) participated in the 2016 J.P. Morgan Corporate Challenge (https://www.jpmorganchasecc.com/events.php?city_id=8&page=events061516) , which took place June 15th in Frankfurt, Germany.
May 27, 2016 CordenPharma International would like to notify customers about a warning letter received from the USFDA on May 24, 2016 in its CordenPharma Latina facility in Sermoneta, Italy. This action follows an earlier inspection of the site by the agency in May 2015. This matter is being considered throughout the organization with the utmost sense of urgency.
May 20, 2016
The pharmaceutical industry is booming, and global giant CordenPharma is well positioned to share in the spoils with its offering of a one-stop supply shop.
May 02, 2016 ICIG’s CordenPharma Group today announced the closing of a syndicated loan of EUR 60 Million. CordenPharma successfully closed its first syndicated loan on advantageous terms.
Apr 22, 2016 Drug Conjugation > How Technology Drives the Supply Chain by Dr. Mimoun Ayoub Director, Global Peptides, Lipids, Carbohydrates & Injectables Platforms, CPI
Apr 22, 2016 Targeted Delivery of Nucleic Acids via Carbohydrate-Protein Interactions by Dr. Stewart Campbell Head of Business Development & Product Management, Carbohydrates, CordenPharma Switzerland
Apr 13, 2016 Read CordenPharma's article contribution titled CordenPharma: Full-Service Capabilities Geared to Meeting Aggressive Timelines (http://www.drug-dev.com/Main/Back-Issues/SPECIAL-FEATURE-OutsourcingFormulation-Developmen-1095.aspx) from Luca Porcu, Director, Global Small Molecules Platform, in the Drug
Development & Delivery April 2016 special feature on 'Outsourcing Formulation Development & Manufacturing: Using a Single Provider Reduces Costs & Risk'.
Apr 13, 2016 AUSTIN, Texas & OKLAHOMA CITY >> Caisson Biotech, LLC (http://www.caissonbiotech.com/) (Caisson), a leader in half-life extension and drug delivery, today announced it has established a global manufacturing partnership with CordenPharma International (CordenPharma), a full-service Contract Development & Manufacturing Organization (CDMO) manufacturing APIs and Drug Products through a network of cGMP facilities across Europe and the US.
Apr 07, 2016 During the DCAT Member Forum on Monday, March 14, 2016 of DCAT Week '16 (http://www.dcat.org/Pages/week_DCATWeek.aspx) at the Waldorf Astoria in New York City, Dr. Roberto
Margarita, Director, Global Antibiotics, Highly Potent & Oncology Platforms, CPI, presented 4 CordenPharma announcements to the DCAT Community.
Apr 01, 2016 International Chemical Investors Group (ICIG) today announced the completion of its acquisition of Sandoz Industrial Products GmbH, a Frankfurt-Höchst based manufacturer of enzyme-based fermentation products and intermediates for the pharmaceutical industry, from Novartis Group. Sandoz Industrial Products GmbH will be re-named Corden BioChem GmbH and will be associated with the CordenPharma Group, the pharma platform of ICIG.
Mar 30, 2016 Click here (http://www.werbefotografie.de/0corden/) to watch a video fo the newly expanded CordenPharma Plankstadt Highly Potent Development facility.
Mar 14, 2016 As part of a long term strategy to meet increasing customer demands, CordenPharma has completed two additional key investments to strengthen its development and manufacturing capabilities for Drug Product service offerings across its Highly Potent, Oncology and Injectables Platforms.
Mar 03, 2016 Where do you see your company's role in the pharmaceutical supply chain? With well-structured product & service offerings organized under the umbrella of six distinctive technology platforms – Peptides/Lipids/Carbohydrates, Injectables, Antibiotics, Highly Potent, Oncology and Small Molecules - CordenPharma is well-positioned as a key CDMO supplier and partner to the pharmaceutical industry.
Feb 24, 2016 International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement under which ICIG will acquire all of the shares in Sandoz Industrial Products GmbH, a Frankfurt-Höchst based manufacturer of enzyme-based fermentation products and intermediates for the pharmaceutical industry, especially for the use in antibiotics. Closing of the transaction is anticipated to occur on 1 April 2016.
Feb 16, 2016 CordenPharma Colorado (http://domain.com/facilities/colorado/) announces successful results from their recent 5 Day Intensive FDA Audit: no 483-observations and a No Action Indicated (NAI) status.
Feb 02, 2016 IBC interviews upcoming Tides 2016 Speaker (http://www.ibclifesciences.com/TIDES/peptidemanufacturing.xml) Dr. Mimoun Ayoub, Director, Global Peptides, Lipids, Carbohydrates & Injectables
Platforms, on the role peptide vaccines play in the development of novel cancer therapies.
Jan 25, 2016 Following the acquisition of ORPEGEN Peptide Chemicals GmbH (http://www.cordenpharma.com/cordenpharma-acquires-the-assets-of-orpegen/) on January 1, 2015,
CordenPharma International announces that on July 1,2015, the non-GMP facility and personnel moved to a location in Frankfurt-Fechenheim now called CordenPharma Frankfurt.
Dec 16, 2015 View the video of the Pharma Integrates 2015 panel discussion Optimising the Product-Performance Model (http://domain.com/pharma-integrates-2015-panel-video-luca-porcu/) with panelist Luca Porcu, Director, Global Highly Potent & Small Molecules Platforms.
Oct 30, 2015 Robbinsville, NJ, USA > October 26, 2015 – The Drug, Chemical & Associated Technology Association (DCAT) is pleased to announce that Dr. Roberto Margarita, Director, Global Antibiotics & Oncology Platforms at CordenPharma International has been elected by the membership to serve on DCAT’s Advisory Council for a three-year term beginning November 1, 2015.
Oct 07, 2015 Amy Doane & Robin Livingston of CordenPharma Colorado (http://domain.com/facilities/colorado/) discuss innovative solutions to ensure containment of Highly Potent Active Pharmaceutical Ingredients (HPAPIs).
Oct 06, 2015 Dr. Roberto Margarita, Director of the Global Antibiotics (http://domain.com/antibiotics-platform/) & Oncology (http://domain.com/oncology-platform/) Platforms, and Luca Porcu, Director of the Global Highly Potent (http://domain.com/highly-potent-platform/) & Small Molecules (http://domain.com/small-moleculesplatform/) Platforms, look at the many elements needed for a successful containment progamme.
Jul 13, 2015 CordenPharma is pleased to announce that the Sterile Oncology Suite in its CordenPharma Latina (http://domain.com/facilities/latina/) (IT) manufacturing facility has received approval for Clinical Supply of
Sterile Oncology Lyophilised Products.
Jul 06, 2015 Dr. Roberto Margarita, Director, Global Antibiotics & Oncology Platforms, CPI - Pharmaceutical Technology Thought Leader Profile - Resistance to Antibiotics is Driving A New Product Wave With Innovative Challenges.
Jul 03, 2015 In a recent article in Manufacturing Chemist Pharma, CordenPharma Colorado (http://domain.com/facilities/colorado/) was mentioned in an update by SafeBridge Consultants as a
manufacturing organisation which continues to maintain effective performance in the recognition, evaluation and control of highly potent compounds.
Jun 09, 2015 International Chemical Investors Group (ICIG) recently announced an agreement with INEOS and Solvay to acquire certain chlorovinyls assets being divested by INOVYN / INEOS. This agreement, which has been reviewed in the context of the merger control process of both this transaction and the INOVYN JV, has now received approval of the European Commission (http://domain.com/images/press-releases/20150609_pressrelease-ec_chlorovinyls-acquisition.pdf/) . The closing of the acquisition of the remedy business by ICIG is
anticipated to be August 1, 2015.
May 11, 2015 Cover Story >> Peptide Vaccines: A Promising Therapeutic Approach. Addressing the CMC Challenges > Chemica Oggi Oligo & Peptide Supplement, April 2015 > by Dr. Mimoun Ayoub, Global Director, Peptides / Lipids / Carbohydrates & Injectables Platforms, CPI.
May 09, 2015 Article >> The Expansion of the Therapeutic Applications of Peptides: Drivers & Challenges > Chimica Oggi Oligo & Peptide Supplement, April 2015 > Interview of Dr. Mimoun Ayoub, Global Director, Peptides / Lipids / Carbohydrates & Injectables Platforms, CPI.
May 08, 2015 Article >> Prospects Through Pharmaceutical Partnership > EuroAsia Industry Magazine, Issue 4/2015 > Interview by Ernesto Petroselli, Presdident, CordenPharma International.
May 08, 2015 Article >> Outsourcing Formulation & Manufacturing Development > Drug Development & Delivery, April 2015, Volume 15 > Contribution by Dr. Roberto Margarita, Global Director Antibiotics & Oncology Platforms, CPI
Mar 18, 2015 CordenPharma is the winner of the 2015 Life Science Leader (http://cmoleadershipawards.com/) CMO Leadership Industry Choice Award for Big Pharma on March 18th at their awards ceremony in New York City.
Mar 18, 2015 Nanobiotix (http://www.nanobiotix.com/) , a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces it has appointed CordenPharma as its manufacturing partner.
Mar 03, 2015 Effective March 5, 2015, CordenPharma Switzerland (http://domain.com/facilities/switzerland/) announces a transfer and change to the US Catalogue Product order process for small pack Phospholipids (1g and 10g) and Pseudoprolines (10g and 25g).
Mar 02, 2015 Peptisyntha (http://domain.com/peptisyntha/) , a CordenPharma facility near Brussels, Belgium, announces a successful completion of their recent FDA inspection.
Feb 19, 2015 On Wednesday March 18, 2015 CordenPharma will be recognized with 9 CMO Leadership Awards presented by Life Science Leader (http://www.lifescienceleader.com/) magazine. The Life Science Leader CMO Leadership Awards are determined through industry research conducted by Nice Insight (http://www.niceinsight.com/) .
Jan 16, 2015 On January 1, 2015 CordenPharma International acquired the assets of Orpegen Peptide Chemicals GmbH, located in Heidelberg, Germany, retaining both their experienced personnel and peptide capabilities. The newly acquired subsidiary, to be named CordenPharma Heidelberg, will provide innovative, cutting-edge process research and non-GMP development services.
Oct 27, 2014 CordenPharma Plankstadt announces today successful results from their recent 5 day intensive FDA Inspection: no 483-observations were found and no recommendations were given.
Apr 28, 2014 The Denver Post recently named CordenPharma Colorado (http://domain.com/facilities/colorado/) as one of the Top Places to Work in Colorado (http://www.topworkplaces.com/frontend.php/regionallist/company/denverpost/corden-pharma-colorado) .
Feb 21, 2014 Effective February 1, 2014, CordenPharma Switzerland transfers their Amino Acid Building Blocks portfolio to Chemie Uetikon GmbH, based in Lahr, Germany
Jan 27, 2014 CordenPharma Colorado announces receipt of approval for the "Potent Compound Safety Certification" by SafeBridge® Consultants, Inc. for the safe handling of potent APIs and compounds of unknown toxicity and potency.
Nov 01, 2013 On October 31, 2013 CordenPharma acquired Ancora Pharmaceuticals (http://www.ancorapharma.com/) , located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of highquality complex synthetic molecules.
Sep 25, 2013 International Chemical Investors Group (ICIG) and Casella GmbH have reached an agreement in principle under which ICIG would acquire all of the shares of Allessa GmbH. Both parties have agreed not to disclose the purchase price.
Sep 03, 2013 CordenPharma Caponago was recently granted SHE Certification with an OH SAS 18001:2007 Certificate for the maintenance of their Safety Management System involving manufacturing activities and the packaging and control of injectable liquid, freeze-dried and powder products.
Aug 28, 2013 International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the deal, expected later this fall, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptides manufacturing.
Jun 13, 2013 In an article on June 7th of The Boulder County Business Report, the city of Boulder, Colorado was cited for national recognition as an innovation hub in various informal polls.
Jun 03, 2013 ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
May 06, 2013 Visit our upcoming poster Development of a Scalable Process for CNP-22, presented by Valerie Paulsen, Principal Analytical Chemist, CordenPharma Colorado at Tides 2013 (http://www.ibclifesciences.com/TIDES/overview.xml) , May 12 - 15 in Boston.
Apr 05, 2013 In a recent issue of their e-newslettter PrepLC eNews, the R&D staff at Phenomenex interviews Dr. Brad DeHoff, Director of R&D for CordenPharma Colorado, about current and future trends of the CMO industry.
Mar 22, 2013 International Chemical Investors Group (ICIG) kicks off €50+ million investment at PPC, a company of WeylChem Group, the fine chemicals platform of ICIG, to develop membrane-based technology. PPC is located in Thann, France.
Mar 08, 2013 In an article published on March 4th in Chemical & Engineering News, CordenPharma Colorado (http://domain.com/facilities/colorado/) was named an approved peptide supplier to Ironwood Pharmaceuticals (http://www.ironwoodpharma.com/) for their product Linaclotide:
Mar 05, 2013 On Thursday, February 28th CordenPharma Colorado sponsored and sent 3 scientists to serve as jurors for the CordenPharma Colorado Regional Science Fair, which took place at on the University of Colorado campus in Boulder.
Feb 13, 2013 CordenPharma announces an expansion of manufacturing capabilities due to the recent acquisition by International Chemical Investors Group (ICIG) of Farchemia from the Tessenderlo Group, completed on December 5th, 2012.
Dec 13, 2012 CordenPharma Chenôve receives updated certificate of compliance to cGMP standards from the PDMA in Japan and the ANSM in France.
Nov 30, 2012 CordenPharma Caponago Receives Workplace Conditions Assessment (WCA) Achievement Award Enabled by Intertek.
Oct 24, 2012 Today Orifarm Generics announced that CordenPharma was elected as the Best Supplier in the Orifarm Generics' Supplier Evaluation 2012.
Oct 10, 2012 CordenPharma presents the award for the Most Effective Process Development/Scale-Up Programme at the European Outsourcing Awards on October 10th in Madrid during CPhI 2012. And the winner is....
Oct 09, 2012 Tessenderlo Group (NYSE Euronext: TESB) announced today that it has the intention to sell its pharmaceutical ingredients activities, Farchemia and Calaire Chimie, to International Chemical Investors Group (ICIG), a private industrial holding company. The sale concerns two production sites in France and Italy.
Oct 05, 2012 Today CordenPharma announced the approval of our proprietary generic drug product dossier for Paclitaxel in the reference state (Germany). With this approval CordenPharma is now open to out-licensing the generic Paclitaxel dossier with rights to register, promote and market the drug to esteemed customers in all EU territories.
Aug 09, 2012 CordenPharma will be Gold Sponsors of the Boulder Peptide Symposium, taking place September 26-28, 2012 at the St. Julien Hotel and Spa in Boulder, CO. Read the full story for Discounted Registration Information.
Jul 31, 2012 In the Boulder Daily Camera's annual list of Top 50 Largest Businesses, CordenPharma Colorado ties with Google Inc. at Number 42 ~ click here for the Daily Camera's full article (http://www.dailycamera.com/business/ci_21174558/top-50-businesses-boulder-broomfield-counties) .
Feb 16, 2012 Based on its recent analysis of the pharmaceutical contract manufacturing market, Frost & Sullivan recognises CordenPharma with the 2011 Western Europe Frost & Sullivan Award for Product Differentiation Excellence.
Oct 06, 2011 We are pleased to announce that on September 1, 2011 International Chemical Investors Group (ICIG) acquired a former division of Roche to join their pharmaceutical platform CordenPharma International as CordenPharma Colorado.
Feb 03, 2011 Luxembourg – International Chemical Investors Group (ICIG) announced that it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.
Website by Boston Interactive (http://www.bostoninteractive.com/)
©2012 CordenPharma International
Media Contact (http://domain.com/media-contact/)
Impressum (http://domain.com/impressum/)
Terms and Conditions (http://domain.com/terms-and-conditions/)
Privacy Policy (http://domain.com/privacy-policy/) Corden Pharma International GmbH, Otto-Hahn-Strasse, 68723 Plankstadt, Germany.
API Development
Drug Product Development
Sterile Oncology
Bergamo, IT
Antibiotics
(http://domain.com/apis/api-
(http://domain.com/drug-products/drug-product-
(http://domain.com/drug-
(http://domain.com/facilities/farchemia/) (http://domain.com/platforms/antibiotics/) Leadership
development/)
development/)
products/sterile-oncology/)
Boulder, US
API Contract Manufacturing
Drug Product Contract Manufacturing
Oral Oncology
Find Your Expert
Highly Potent & Oncology
(http://domain.com/apis/api-contract- (http://domain.com/drug-products/drug-product-
(http://domain.com/drug-
(http://domain.com/about(http://domain.com/contact(http://domain.com/facilities/colorado/) (http://domain.com/platforms/highly- us/leadership/) us/direct-contact-list/) Brussels, BE potent-oncology-platform/) Our History Schedule an Appt
manufacturing/)
contract-manufacturing/)
products/oral-oncology/)
(http://domain.com/facilities/brussels,Small Molecules
(http://domain.com/about(http://domain.com/contact-
Generic API Manufacturing
Sterile Formulation (http://domain.com/drug-
Two-layer tablets
be/)
(http://domain.com/platforms/small-
us/our-history/)
(http://domain.com/drug-
Caponago, IT
molecules-platform/)
Compliance
(http://domain.com/apis/generic-api- products/sterile-formulation/)
us/schedule-an-appt/)
manufacturing/)
Highly Potent Formulation Oncology
products/two-layer-tablets/)
(http://domain.com/facilities/caponago/) Peptides, Oligonucleotides, Lipids (http://domain.com/about-
Highly Potent APIs
(http://domain.com/drug-products/highly-potent-
Clinical Supply Services
Chenôve, FR
(http://domain.com/apis/highly-
formulation-oncology/)
(http://domain.com/drug-
(http://domain.com/facilities/chenove/) (http://domain.com/platforms/peptides- News and Press
potent-apis/)
Cephalosporin Manufacturing
products/clinical-trial-
Latina, IT
services/)
(http://domain.com/facilities/latina/) Injectables
Packaging
Liestal, CH
Oligonucleotides
(http://domain.com/drug-products/cephalosporin-
(http://domain.com/apis/oligonucleotides/) manufacturing/)
Sterile APIs
Penicillin Manufacturing (http://domain.com/drug-(http://domain.com/drug-
& Carbohydrates lipids-carbohydrates-platform/)
(http://domain.com/about-
us/news-and-press/) (http://domain.com/platforms/injectablesEvents
(http://domain.com/facilities/switzerland/) platform/)
Plankstadt, DE
us/compliance/)
(http://domain.com/about-
Fermentation & Enzymes
(http://domain.com/apis/sterile-apis/) products/pencillin-manufacturing/)
products/packaging/)
Peptides
Parenterals (http://domain.com/drug-
Pharma-Logistics
us/events/) (http://domain.com/facilities/plankstadt/) (http://domain.com/platforms/cordenbiochem/) ICIG
(http://domain.com/apis/peptides/)
products/parenterals/)
(http://domain.com/drug-
CordenBioChem
(http://domain.com/about-
Building Blocks
Large Pre-Filled Syringes
products/pharma-logistics/)
(http://domain.com/facilities/cordenbiochem/)
us/icig/)
(http://domain.com/apis/building-
(http://domain.com/drug-products/large-pre-filled-
Support Services
Careers
blocks/)
syringes/)
(http://domain.com/drug-
(http://domain.com/about-
Conjugate Products
products/support-services/)
(http://domain.com/apis/conjugateproducts/)
Carbohydrates (http://domain.com/apis/carbohydrates/)
Derivatized Phospholipids (http://domain.com/apis/derivitizedphospholipids/)
Support Services (http://domain.com/apis/supportservices-for-apis/)
us/careers/)